Atorvastatin Calcium; Ezetimibe Patent Expiration
Atorvastatin Calcium; Ezetimibe is Used for lowering cholesterol levels in individuals with primary hyperlipidemia, mixed hyperlipidemia, or homozygous familial hypercholesterolemia. It was first introduced by Organon Llc A Sub Of Organon And Co
Atorvastatin Calcium; Ezetimibe Patents
Given below is the list of patents protecting Atorvastatin Calcium; Ezetimibe, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Liptruzet |
USRE42461 (Pediatric) | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
Apr 25, 2017
(Expired) | Organon |
| Liptruzet |
US5969156 (Pediatric) | Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
Jan 08, 2017
(Expired) | Organon |
| Liptruzet | USRE42461 | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
Oct 25, 2016
(Expired) | Organon |
| Liptruzet | US5969156 | Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
Jul 08, 2016
(Expired) | Organon |
| Liptruzet |
US5686104 (Pediatric) | Stable oral CI-981 formulation and process of preparing same |
May 11, 2015
(Expired) | Organon |
| Liptruzet | US5686104 | Stable oral CI-981 formulation and process of preparing same |
Nov 11, 2014
(Expired) | Organon |
| Liptruzet |
US5846966 (Pediatric) | Combinations of hydroxy-substituted azetidinone compounds and HMG CoA Reductase Inhibitors |
Mar 21, 2014
(Expired) | Organon |
| Liptruzet | US5846966 | Combinations of hydroxy-substituted azetidinone compounds and HMG CoA Reductase Inhibitors |
Sep 21, 2013
(Expired) | Organon |
Atorvastatin Calcium; Ezetimibe's Family Patents
Explore Our Curated Drug Screens
Atorvastatin Calcium; Ezetimibe Generic API Manufacturers
Several generic applications have been filed for Atorvastatin Calcium; Ezetimibe.
Given below is the list of companies who have filed for Atorvastatin Calcium; Ezetimibe generic, along with the locations of their manufacturing plants worldwide.
1. ALTHERA PHARMS
Althera Pharmaceuticals Llc has filed for 4 different strengths of generic version for Atorvastatin Calcium; Ezetimibe. All of these versions come by the name LYPQOZET. Given below are the details of the strengths of this generic introduced by Althera Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE; 10MG | tablet | Prescription | ORAL | N/A | Apr 26, 2017 |
| EQ 20MG BASE; 10MG | tablet | Prescription | ORAL | N/A | Apr 26, 2017 |
| EQ 40MG BASE; 10MG | tablet | Prescription | ORAL | N/A | Apr 26, 2017 |
| EQ 80MG BASE; 10MG
(reference standard) | tablet | Prescription | ORAL | N/A | Apr 26, 2017 |